DeepMed Research

MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

Effectiveness of Aripiprazole for Improving Side Effects of Clozapine in the Treatment of People With Schizophrenia

Phase 4

Completed

Conditions: Schizophrenia
Insulin Resistance

Interventions: Drug: Aripiprazole
Drug: Placebo

First Posted Date: 2006-06-27

Last Posted Date: 2014-06-23

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 38

Registration Number: NCT00345033

Locations: 🇺🇸
Massachusetts General Hospital Schizophrenia Program, Boston, Massachusetts, United States

Modified Directly Observed Therapy for Improving Antiretroviral Therapy Adherence in People With HIV

Not Applicable

Completed

Conditions: HIV Infections

Interventions: Behavioral: Modified Directly Observed Therapy
Behavioral: Standard Care

First Posted Date: 2006-06-20

Last Posted Date: 2013-04-19

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 150

Registration Number: NCT00339092

Locations: 🇺🇸
UCSF Market Street Study Site, San Francisco, California, United States

Antidepressant Medication Plus Directly Observed Therapy for Improving Adherence to Antiretroviral Therapy

Phase 2

Completed

Conditions: Depression
HIV Infections

Interventions: Behavioral: Directly Observed Therapy (DOT)
Drug: Fluoxetine

First Posted Date: 2006-06-20

Last Posted Date: 2013-11-15

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 150

Registration Number: NCT00338767

Locations: 🇺🇸
UCSF Market Street Study Site, San Francisco, California, United States

Rosiglitazone for Clozapine Induced Glucose Metabolism Impairment

Phase 4

Completed

Conditions: Schizophrenia

Interventions: Drug: placebo
Drug: rosiglitazone

First Posted Date: 2006-06-15

Last Posted Date: 2015-05-08

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 20

Registration Number: NCT00337350

Locations: 🇺🇸
Massachusetts General Hospital Schizophrenia Program, Boston, Massachusetts, United States

Aromatase Activity and Ovarian Growth Factors in African-American Versus Caucasian Women

Not Applicable

Conditions: Healthy
Fragile X Syndrome

Interventions: Procedure: Follicle Aspiration

First Posted Date: 2006-06-08

Last Posted Date: 2013-11-06

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 116

Registration Number: NCT00334971

Locations: 🇺🇸
Reproductive Endocrine Unit, Massachusetts General Hospital, Boston, Massachusetts, United States

A Comparison Study of the Efficacy and Tolerability of Depakote ER and Depakote DR

Phase 4

Completed

Conditions: Mania
Mixed Mania

Interventions: Drug: Depakote ER
Drug: Depakote DR

First Posted Date: 2006-06-07

Last Posted Date: 2007-12-06

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 5

Registration Number: NCT00334347

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

A Study of 6(S)-5-MTHF Among Serotonin Reuptake Inhibitor(SSRI)-Resistant Outpatients With Major Depressive Disorder (MDD)

Phase 4

Completed

Conditions: Major Depressive Disorder

Interventions: Other: 6(S)-5-MTHF (a Medical Food)

First Posted Date: 2006-05-03

Last Posted Date: 2010-06-08

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 150

Registration Number: NCT00321152

Locations: 🇺🇸
Burlington Medical Associates, Burlington, Massachusetts, United States
🇺🇸
Lousiana State University Health Sciences Center, New Orleans, Louisiana, United States
🇺🇸
Waltham Family Practice, Waltham, Massachusetts, United States

and more 8 locations

EEG Studies of Sensory Processing in Autistic Children

Conditions: Autism

First Posted Date: 2006-04-27

Last Posted Date: 2010-05-04

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 130

Registration Number: NCT00319722

Locations: 🇺🇸
MGH LADDERS Clinic, Lexington, Massachusetts, United States

The Partners Genetics Collaborative Study of Schizophrenia

Completed

Conditions: Schizophrenia

First Posted Date: 2006-04-27

Last Posted Date: 2017-10-19

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 451

Registration Number: NCT00319904

Locations: 🇺🇸
Freedom Trail Clinic, Boston, Massachusetts, United States

Study of Nesiritide in Diastolic Heart Failure.

Phase 1

Completed

Conditions: Diastolic Heart Failure

First Posted Date: 2006-04-03

Last Posted Date: 2014-03-26

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 20

Registration Number: NCT00309868

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy